(Q39613391)

English

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study

scientific article published on 23 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Francis Eustache

9

object named as

Francis Eustache

0 references

Gareth R. Jones

object named as

Gareth Jones

5

0 references

Pierrick Bourgeat

object named as

Pierrick Bourgeat

4

0 references

Olivier Salvado

object named as

Olivier Salvado

10

0 references

Colin L. Masters

11

object named as

Colin L Masters

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Nicolas Villain

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gaël Chételat

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Blandine Grassiot

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Kathryn A Ellis

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

David Ames

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ralph N Martins

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Christopher C Rowe

12

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Victor L Villemagne

13

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

AIBL Research Group

14

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

23 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pt 7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2126-2139

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Classification and basic pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The clinical use of structural MRI in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Alzheimer's disease: progress in prediction

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Neuropathologic features of amnestic mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Longitudinal imaging in dementia.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Longitudinal patterns of β-amyloid deposition in nondemented older adults

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Testing the right target and right drug at the right stage

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The importance of neuritic plaques and tangles to the development and evolution of AD

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

The Alzheimer's disease neuroimaging initiative: progress report and future plans

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Template-O-Matic: a toolbox for creating customized pediatric templates

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS125

21 January 2018

Identifiers

10.1093/BRAIN/AWS125

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39613391&oldid=1845428218"